annual cash & cash equivalents:
$530.23M-$38.27M(-6.73%)Summary
- As of today (June 14, 2025), NVAX annual cash & cash equivalents is $530.23 million, with the most recent change of -$38.27 million (-6.73%) on December 31, 2024.
- During the last 3 years, NVAX annual cash & cash equivalents has fallen by -$984.89 million (-65.00%).
- NVAX annual cash & cash equivalents is now -65.00% below its all-time high of $1.52 billion, reached on December 31, 2021.
Performance
NVAX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$263.34M-$266.89M(-50.34%)Summary
- As of today (June 14, 2025), NVAX quarterly cash & cash equivalents is $263.34 million, with the most recent change of -$266.89 million (-50.34%) on March 31, 2025.
- Over the past year, NVAX quarterly cash & cash equivalents has dropped by -$217.25 million (-45.20%).
- NVAX quarterly cash & cash equivalents is now -87.31% below its all-time high of $2.07 billion, reached on June 30, 2021.
Performance
NVAX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NVAX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.7% | -45.2% |
| 3 y3 years | -65.0% | -83.2% |
| 5 y5 years | +572.7% | +46.4% |
NVAX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.0% | at low | -83.2% | at low |
| 5 y | 5-year | -65.0% | +572.7% | -87.3% | +46.4% |
| alltime | all time | -65.0% | >+9999.0% | -87.3% | >+9999.0% |
NVAX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $263.34M(-50.3%) |
| Dec 2024 | $530.23M(-6.7%) | $530.23M(-7.6%) |
| Sep 2024 | - | $573.63M(-15.7%) |
| Jun 2024 | - | $680.16M(+41.5%) |
| Mar 2024 | - | $480.59M(-15.5%) |
| Dec 2023 | $568.50M(-57.5%) | $568.50M(-12.7%) |
| Sep 2023 | - | $651.10M(+28.7%) |
| Jun 2023 | - | $505.91M(-19.0%) |
| Mar 2023 | - | $624.95M(-53.3%) |
| Dec 2022 | $1.34B(-11.8%) | $1.34B(+4.4%) |
| Sep 2022 | - | $1.28B(-6.9%) |
| Jun 2022 | - | $1.38B(-12.4%) |
| Mar 2022 | - | $1.57B(+3.7%) |
| Dec 2021 | $1.52B(+173.8%) | $1.52B(-21.8%) |
| Sep 2021 | - | $1.94B(-6.6%) |
| Jun 2021 | - | $2.07B(+4.0%) |
| Mar 2021 | - | $2.00B(+260.6%) |
| Dec 2020 | $553.40M(+602.1%) | $553.40M(+65.6%) |
| Sep 2020 | - | $334.17M(-21.3%) |
| Jun 2020 | - | $424.39M(+135.9%) |
| Mar 2020 | - | $179.88M(+128.2%) |
| Dec 2019 | $78.82M(+12.4%) | $78.82M(+10.8%) |
| Sep 2019 | - | $71.17M(-1.2%) |
| Jun 2019 | - | $72.00M(-26.3%) |
| Mar 2019 | - | $97.71M(+39.3%) |
| Dec 2018 | $70.15M(-34.0%) | $70.15M(+24.2%) |
| Sep 2018 | - | $56.50M(-36.1%) |
| Jun 2018 | - | $88.47M(-22.0%) |
| Mar 2018 | - | $113.40M(+6.7%) |
| Dec 2017 | $106.31M(-26.4%) | $106.31M(+2.0%) |
| Sep 2017 | - | $104.25M(+37.5%) |
| Jun 2017 | - | $75.79M(-20.9%) |
| Mar 2017 | - | $95.85M(-33.6%) |
| Dec 2016 | $144.35M(+55.0%) | $144.35M(+20.3%) |
| Sep 2016 | - | $119.95M(+34.2%) |
| Jun 2016 | - | $89.39M(-32.4%) |
| Mar 2016 | - | $132.22M(+42.0%) |
| Dec 2015 | $93.11M(+187.9%) | $93.11M(-32.6%) |
| Sep 2015 | - | $138.14M(-17.5%) |
| Jun 2015 | - | $167.38M(-22.2%) |
| Mar 2015 | - | $215.05M(+565.1%) |
| Dec 2014 | $32.34M(-72.9%) | $32.34M(-6.2%) |
| Sep 2014 | - | $34.47M(-66.8%) |
| Jun 2014 | - | $103.86M(-5.5%) |
| Mar 2014 | - | $109.92M(-8.0%) |
| Dec 2013 | $119.47M(+586.7%) | $119.47M(-2.5%) |
| Sep 2013 | - | $122.49M(+4658.9%) |
| Jun 2013 | - | $2.57M(-71.5%) |
| Mar 2013 | - | $9.02M(-48.1%) |
| Dec 2012 | $17.40M(+23.4%) | $17.40M(+62.0%) |
| Sep 2012 | - | $10.74M(-30.0%) |
| Jun 2012 | - | $15.33M(+10.5%) |
| Mar 2012 | - | $13.87M(-1.6%) |
| Dec 2011 | $14.10M(+75.0%) | $14.10M(-1.5%) |
| Sep 2011 | - | $14.32M(+9.4%) |
| Jun 2011 | - | $13.09M(+56.6%) |
| Mar 2011 | - | $8.36M(+3.7%) |
| Dec 2010 | $8.06M | $8.06M(-50.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | $16.21M(+71.7%) |
| Jun 2010 | - | $9.45M(-35.2%) |
| Mar 2010 | - | $14.57M(-62.4%) |
| Dec 2009 | $38.76M(+43.9%) | $38.76M(+29.3%) |
| Sep 2009 | - | $29.98M(+18.9%) |
| Jun 2009 | - | $25.22M(+28.5%) |
| Mar 2009 | - | $19.63M(-27.1%) |
| Dec 2008 | $26.94M(+519.3%) | $26.94M(-26.8%) |
| Sep 2008 | - | $36.79M(+56.5%) |
| Jun 2008 | - | $23.51M(+59.9%) |
| Mar 2008 | - | $14.70M(+238.0%) |
| Dec 2007 | $4.35M(-39.3%) | $4.35M(-72.5%) |
| Sep 2007 | - | $15.82M(+115.6%) |
| Jun 2007 | - | $7.34M(-5.7%) |
| Mar 2007 | - | $7.78M(+8.7%) |
| Dec 2006 | $7.16M(-77.5%) | $7.16M(-66.4%) |
| Sep 2006 | - | $21.29M(-72.9%) |
| Jun 2006 | - | $78.60M(-6.4%) |
| Mar 2006 | - | $83.94M(+163.2%) |
| Dec 2005 | $31.89M(+78.4%) | $31.89M(+359.3%) |
| Sep 2005 | - | $6.94M(+56.3%) |
| Jun 2005 | - | $4.44M(-51.7%) |
| Mar 2005 | - | $9.20M(-48.5%) |
| Dec 2004 | $17.88M(-35.3%) | $17.88M(-35.0%) |
| Sep 2004 | - | $27.50M(+76.0%) |
| Jun 2004 | - | $15.62M(-28.6%) |
| Mar 2004 | - | $21.89M(-20.8%) |
| Dec 2003 | $27.63M(+819.6%) | $27.63M(+357.1%) |
| Sep 2003 | - | $6.04M(-37.2%) |
| Jun 2003 | - | $9.63M(-32.8%) |
| Mar 2003 | - | $14.32M(+376.5%) |
| Dec 2002 | $3.00M(-85.0%) | $3.00M(-60.6%) |
| Sep 2002 | - | $7.63M(-52.1%) |
| Jun 2002 | - | $15.93M(+46.3%) |
| Mar 2002 | - | $10.88M(-45.7%) |
| Dec 2001 | $20.05M(+34.9%) | $20.05M(-14.0%) |
| Sep 2001 | - | $23.30M(+103.7%) |
| Jun 2001 | - | $11.44M(+28.6%) |
| Mar 2001 | - | $8.89M(-40.2%) |
| Dec 2000 | $14.86M(+2023.4%) | $14.86M(+47.8%) |
| Sep 2000 | - | $10.06M(-18.1%) |
| Jun 2000 | - | $12.29M(-16.4%) |
| Mar 2000 | - | $14.69M(+1999.0%) |
| Dec 1999 | $700.00K(-30.0%) | $700.00K(-30.0%) |
| Sep 1999 | - | $1.00M(-64.3%) |
| Jun 1999 | - | $2.80M(+833.3%) |
| Mar 1999 | - | $300.00K(-70.0%) |
| Dec 1998 | $1.00M(-73.7%) | $1.00M(-86.1%) |
| Sep 1998 | - | $7.20M(-13.3%) |
| Jun 1998 | - | $8.30M(-9.8%) |
| Mar 1998 | - | $9.20M(+142.1%) |
| Dec 1997 | $3.80M(+52.0%) | $3.80M(-20.8%) |
| Sep 1997 | - | $4.80M(-17.2%) |
| Jun 1997 | - | $5.80M(-14.7%) |
| Mar 1997 | - | $6.80M(+172.0%) |
| Dec 1996 | $2.50M | $2.50M(+19.0%) |
| Sep 1996 | - | $2.10M(-30.0%) |
| Jun 1996 | - | $3.00M(-23.1%) |
| Mar 1996 | - | $3.90M |
FAQ
- What is Novavax annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Novavax?
- What is Novavax annual cash & cash equivalents year-on-year change?
- What is Novavax quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Novavax?
- What is Novavax quarterly cash & cash equivalents year-on-year change?
What is Novavax annual cash & cash equivalents?
The current annual cash & cash equivalents of NVAX is $530.23M
What is the all time high annual cash & cash equivalents for Novavax?
Novavax all-time high annual cash & cash equivalents is $1.52B
What is Novavax annual cash & cash equivalents year-on-year change?
Over the past year, NVAX annual cash & cash equivalents has changed by -$38.27M (-6.73%)
What is Novavax quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of NVAX is $263.34M
What is the all time high quarterly cash & cash equivalents for Novavax?
Novavax all-time high quarterly cash & cash equivalents is $2.07B
What is Novavax quarterly cash & cash equivalents year-on-year change?
Over the past year, NVAX quarterly cash & cash equivalents has changed by -$217.25M (-45.20%)